Overview
Melissa Storms is a Nurse Practitioner in Hanover, New Hampshire. Ms. Storms is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Mary Hitchcock Memorial Hospital
Katherine Rose is a Nurse Practitioner in Lebanon, New Hampshire. Ms. Rose is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Elaine Owen is a Nurse Practitioner in Berlin, Vermont. Ms. Owen is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Smoldering Multiple Myeloma, ALK-Positive Non-Small Cell Lung Cancer, Myeloproliferative Neoplasms (MPN), and Relapsed Refractory Multiple Myeloma (RRMM). Ms. Owen is currently accepting new patients.
Laura Drenen is a Nurse Practitioner in Morrisville, Vermont. Ms. Drenen is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Smoldering Multiple Myeloma, and Secondary Adrenal Insufficiency. Ms. Drenen is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerMs. Storms isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.